Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of ...
An expert has flagged the common signs of diabetes, including a common nighttime habit. As World Diabetes Day was marked on ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
The Air Quality Index (AQI) remains severe to hazardous in Delhi NCR which is a leading cause of the rise in respiratory and chest infection cases in hospitals. According to Dr Sudhir Gupta, senior ...
Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.